HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
0.4500
-0.5400 (-54.55%)
May 6, 2026, 3:32 PM EST
HST Global Market Cap
HST Global has a market cap or net worth of $140.02 million as of May 6, 2026. Its market cap has increased by 20,420.95% in one year.
Market Cap
140.02M
Enterprise Value
140.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.45
Market Cap Chart
Since May 12, 2008, HST Global's market cap has increased from 11.89M to 140.02M, an increase of 1,078.03%. That is a compound annual growth rate of 14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 140.02M | 6.31% |
| Dec 9, 2025 | 131.71M | 224.37% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 349.96M |
| Silence Therapeutics | 336.78M |
| Vaxart | 182.74M |
| Glorywin Entertainment Group | 149.60M |
| NDT Pharmaceuticals | 114.12M |
| BioStem Technologies | 74.62M |
| Sangamo Therapeutics | 73.58M |
| Nuo Therapeutics | 58.08M |